NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.80% |
| AGIO | Agios Pharm | Healthcare | Biotechnology | 1.79% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 1.73% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.68% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 1.67% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 1.66% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.65% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.65% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.65% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 1.65% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.65% |
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.65% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 1.64% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.64% |
| NVAX | Novavax Inc | Healthcare | Biotechnology | 1.64% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.64% |
| PHAT | Phathom Pharmaceuticals Inc | Healthcare | Biotechnology | 1.63% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.63% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.63% |